COMP <GO>
EML vs ACU // DIVIDEND YIELD & FCF PAYOUT SAFETY
Eastern Company (NASDAQ) VS. Acme United Corporation. (NYSE) • 15-METRIC TALLY: EML 3
— ACU 10
▲ DIVIDEND YIELD & FCF PAYOUT SAFETY LEADER: EML
LAST: $27.67 (+3.25%) • MKT CAP: $166.5M
dividend-safety
1.61%
LAST: $68.11 (+1.89%) • MKT CAP: $261.1M
dividend-safety
0.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EML VS. ACU)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EML | ACU | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 22.90% | 39.40% | -16.50 | ACU | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 5.60% | 9.20% | -3.60 | ACU | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.7x | 11.3x | +2.40 | ACU | /valuation <GO> |
| Free Cash Flow Yield | 2.94% | 2.90% | +0.04 | EML | /fcf-yield <GO> |
| Operating Margin | 4.30% | 7.50% | -3.20 | ACU | /operating-margins <GO> |
| Net Profit Margin | 2.90% | 5.20% | -2.30 | ACU | /net-margins <GO> |
| Revenue Growth (YoY) | -8.70% | 1.10% | -9.80 | ACU | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 1.61% | 0.90% | +0.71 | EML | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.69 | 5.72 | -2.03 | ACU | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | ACU | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 66.1 | 69.7 | -3.60 | ACU | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.7x | 23.8x | -2.10 | EML | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $166.5M | $261.1M | -$94.6M | ACU | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EML REV | ACU REV | EML GROSS % | ACU GROSS % | EML FCF | ACU FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $249.0M | $196.5M | 22.9% | 39.4% | $4.9M | $7.6M |
| FY 2024 | $272.8M | $194.5M | 24.7% | 39.3% | $9.7M | $4.8M |
| FY 2023 | $258.9M | $191.5M | — | — | $25.5M | $28.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EML // BETA —
ACU // BETA —